Pfizer to pay $2.26B for cancer treatment developer Trillium
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay
Read morePfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Pfizer will pay
Read more